TIXOCORTOL TEVA 1 %, nasal suspension bottle, 10 ml
Active ingredients: Tixocortol pivalate
Commercialized according to BDPMDispensing in France: Prescription only
Suspensionbottle, 10 mlnasale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TIXOCORTOL TEVA 1 %, suspension nasale
- Pharmaceutical form
- suspension
- Route of administration
- nasale
- Presentation description
- 1 flacon pulvérisateur en polyéthylène de 10 ml avec pompe doseuse avec embout nasal
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Apr 2020
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63016772CIP73016855CIP133400930168554Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIVALATE DE TIXOCORTOLsuspension | 1 g · 100 g de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.